Fundraising FoxAngelini Ventures — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Nobi manufactures intelligent lamps equipped with optical sensors and artificial intelligence to detect falls and monitor health for elderly care in residential facilities and home settings.
AI & Machine LearningHealthtechIoT
Roeland Pelgrims(Founder)inBert De Haes(Founder)Stijn Verrept(Founder)
Co-investors15th RockEQT Life SciencesPMVSkystar Capital
Serenis is an online mental health platform offering video sessions with vetted psychologists, psychotherapists, psychiatrists, coaches, and nutritionists, covering individual, couples, ADHD, psychiatry, sexology, and eating-disorder care.
Digital HealthMarketplacesMental Health
Daniele Francescon(Founder)inSilvia Wang(Founder)
Co-investorsGruppo BertoldiLumen VenturesCDP Venture CapitalInvictus Capital
Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.
BiotechDigital HealthHealthtechMedical DevicesSacramento, US
Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in
BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)
Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsDementia Discovery FundDolby Family VenturesMitsui Global Investment+2 more
Vantis develops AI-based assistance systems and technology for primary care, aimed at supporting physicians in everyday clinical work by simplifying processes and making medical information more usable.
AI & Machine LearningDigital HealthHealthtechMunich, DE
Maximilian Roedel(Founder)
Co-investorsBayBG Venture CapitalBayern Kapitalb2venturefirstminute capital
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.